Japan to ban cannabis ingredient CBN from June

Starting in June, the health ministry will ban the manufacturing, sale, possession and use of the cannabis-derived compound cannabinol (CBN). Japan's health ministry is set to ban the production, sale, possession and use of cannabinol, or CBN, an ingredient derived from cannabis, from June. An animal experiment conducted following reports of apparent health hazards associated with CBN has found that the substance is highly likely to cause symptoms such as hallucinations. The ministry will regulate CBN as a designated drug under the pharmaceutical and medical devices law through a revision of a relevant ordinance. The amended ordinance is set to take effect in June. In a time of both misinformation and too much information, quality journalism is more crucial than ever.